Evotec SE EVO
NASDAQ EVO
$1.95 -0.03 (-1.52%)
As of: Aug 20, 2026 · 3:56 PM EDT

Evotec SE (EVO) Net Margin Growth (1y) (2010 - 2025)

Evotec SE (EVO) Net Margin Growth (1y) (2010 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -2,064.00
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -177.00
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -195.00
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 376.00
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -303.00
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -58.00
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 306.00
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Evotec SE 692.56 Mn 692.08 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.77 Mn
Sep 30, 2025 313.00
Dec 31, 2024 -7.41 Mn
Sep 30, 2024 -4,912.00
Dec 31, 2023 2.00 Mn
Sep 30, 2023 -734.00
Jun 30, 2023 1,025.00
Dec 31, 2022 -8.44 Mn
Sep 30, 2022 -5,691.00
Jun 30, 2022 -5,964.00
Mar 31, 2022 -8,408.00
Dec 31, 2021 4.82 Mn
Dec 31, 2020 173,172.00
Jun 30, 2010 8,944.00
Mar 31, 2010 0.00